Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2025 17:18 ET | Source: Wellgistics Health, Inc.

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure

TAMPA, FL, March 04, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (the “Company”), a holding company for various existing and planned strategic businesses centered around...
February 26, 2025 07:40 ET | Source: Wellgistics Health, Inc.

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

Tampa, Florida, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX, the "Company"), a holding company for various existing and planned strategic businesses centered around...
February 24, 2025 16:05 ET | Source: Wellgistics Health, Inc.

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

Tampa, Florida, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare...
February 21, 2025 08:05 ET | Source: Wellgistics Health, Inc.

Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering

Tampa, Florida, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare...
October 17, 2022 09:29 ET | Source: The Insight Partners

$56+ Billion Home Infusion Therapy Market Size to Grow at a Rapid Pace by 2028 at 8+% CAGR | The Insight Partners

New York, Oct. 17, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Home Infusion Therapy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 –...
January 27, 2022 16:05 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director

PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (“Interpace”) a leader in enabling personalized medicine, is pleased to announce today that Vijay...
February 11, 2015 11:06 ET | Source: Industry Standard Research

ISR Projects a 7.4% Compound Annual Growth Rate for the CRO Market Through 2019

CARY, NC--(Marketwired - February 11, 2015) - Industry Standard Research (ISR Reports) has announced the availability of a new report titled "2015 Edition of the CRO Market Size Projections:...